Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05902507 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging in Radiotherapy for Breast Cancer
A clinical trial, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 20
- Enrollment target
NCT05902507: Recruiting study, sponsored by University of California, San Francisco.
NCT05902507 is a clinical trial that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05902507 is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a single-center, prospective pilot study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatment (RT) for breast cancer.
Primary Outcome
Feasibility feasibility of acquiring MRI simulation prior to RT planning is defined as successfully acquiring MRI data at the specified time point in a participant's radiotherapy (RT) care plan
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging Simulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2027-05-31 |
What NCT05902507 shows while recruiting
NCT05902507 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging Simulation is the first listed.
NCT05902507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05902507 about?
NCT05902507 is a clinical study titled "Magnetic Resonance Imaging in Radiotherapy for Breast Cancer". This is a single-center, prospective pilot study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatment (RT) for breast cancer.
What is the current status of trial NCT05902507?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-05-15. Estimated completion is 2027-05-31.
What interventions are being tested in trial NCT05902507?
The interventions under investigation include: Magnetic Resonance Imaging Simulation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05902507?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI